American HomePatient announces extension of self-tender offer

NewsGuard 100/100 Score

American HomePatient, Inc. (OTCBB: AHOM) ("American HomePatient" or the "Company"), one of the nation's largest home health care providers, today announced that it is extending its previously announced self-tender offer for all outstanding shares of common stock of the Company at $0.67 per share, until 5:00 P.M., New York City time, Wednesday, September 1, 2010, unless the tender offer is further extended. The tender offer was previously set to expire at 5:00 P.M., New York City Time, Wednesday, August 25, 2010.

Furthermore, American HomePatient (with the consent of Highland Capital Management, L.P. ("Highland")) is modifying the tender offer condition that the number of shares tendered, when added to the number of shares owned by Highland and its affiliates, constitutes at least 90% of the then outstanding shares of common stock (the "Minimum Condition"). Instead of 90%, the Minimum Condition will now be satisfied if the number of shares tendered, when added to the number of shares owned by Highland and its affiliates, constitutes at least 80% of the then outstanding shares of common stock.

As of the close of business on August 25, 2010, 6,896,041 shares of common stock had been tendered in and not withdrawn from the offer. These tendered shares, when added to the number of shares owned by Highland and its affiliates, constitute approximately 87% of the outstanding shares of common stock.

American HomePatient, a Nevada corporation, is one of the nation's largest home health care providers with operations in 33 states. Its product and service offerings include respiratory services, infusion therapy, parenteral and enteral nutrition, and medical equipment for patients in their home.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes management program cuts dementia risk in type 2 patients